Chief Scientific Officer
Koneksa Health
Elena Izmailova, Ph.D. (Chief Scientific Officer) leads scientific oversight of scientific strategy and external partnerships at Koneksa Health Inc. Elena has 25 years of experience in academic and industry research. Her academic appointments include Massey Cancer Center, Children’s Hospital (Boston), Harvard Medical School, and MIT. She has worked in various R&D roles at Millennium Pharmaceuticals and Takeda Pharmaceuticals. Elena is a co-founder of the Digital Medicine Society (DiMe) and a member of the Editorial Board of Clinical and Translational Science Journal (ASCPT). Elena has a Ph.D. in Biology; her main scientific interest is clinical biomarker development and validation.
Disclosure information not submitted.
Wednesday, March 16, 2022
3:00 PM – 4:00 PM ET
.png)